Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Molecular Risk Stratification for Decision-Making Among Patients With Breast Cancer Eligible to Omit Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: December 28, 2025
Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients.
Journal: Annals of surgical oncology
Published: February 18, 2025
Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experience.
Journal: Clinical and translational radiation oncology
Published: December 28, 2021
Evaluating the Impact of COVID-19 on Clinical Decision Making During the Initial Outbreak in a High-prevalence Environment.
Journal: International journal of radiation oncology, biology, physics
Published: January 11, 2021
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Journal: Head & neck
Published: April 17, 2019
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial.
Journal: International journal of radiation oncology, biology, physics
Published: August 20, 2018
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
Journal: Blood advances
Published: February 20, 2018
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
Journal: British journal of haematology
Published: August 02, 2017
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
Journal: British journal of haematology
Published: June 04, 2017
Last Updated: 09/26/2026